TP53 and neuroblastoma: Furthermore, in vitro studies performed with neuroblastoma cell lines have shown that cells with mutated TP53 and cells with p53 inactivated by overexpression of the viral oncoprotein E6 are less sensitive to chemotherapy with carboplatin, melphalan, and etoposide [28,35] than those expressing functional p53 [13].